Washington, Sept 14: A new study of cervical cancer patients has revealed that irrespective of being big or small, if a tumour glows brightly in a PET (positron emission tomography) scan, it is likely to be more dangerous than dimmer tumours.

The study conducted by Washington University School of Medicine researchers reveals that PET ‘can reliably identify patients who have a poorer prognosis’.

New Delhi: Dr Reddy’s Laboratories (DRL) has received final approval for its Abbreviated New Drug Application (ANDA) for Ranitidine 150mg pill by the US Food and Drug Administration (FDA)

DRL is the only generic maker to get FDA authorization for this Abbreviated New Drug Application (ANDA) product accompanying the expiry of innovator's patents.

According to a statement, the company will distribute the 150 mg potency in blister counts of 8 and 24’s plus bottles of 50, 65 and 95 counts.

London, Sept 14 (ANI): An overweight mother speeds up her child’s path to obesity, a new study has found.

And, this is especially true if you are European, the study further reports.

The study’s findings are based on a research that involved 571 New Zealand children of European heritage.

As a part of the study, researchers monitored the children from the time of their birth till they turned seven.

Washington: Researchers at the Massachusetts Institute of Technology (MIT) say that they have identified the gene responsible for binocular vision, which may lead to new treatments for sensory disorders in which people experience the strange phenomena of seeing better with one eye covered.

Unlike horses and eagles, whose eyes on the sides of their heads provide two different scenes, humans see a single, in-depth view.

Washington, Sep 14 (ANI): Researchers have discovered a new application for tropical and popular aquarium fish, Zebrafish – it can now be used to study COX deficiencies in humans.

Researchers at the University of Oregon claim that their finding has opened an unparalleled pathway to examine the earliest stages of mitochondrial impairments that lead to potentially fatal metabolic disorders.

Washington, Sept 14: Non-stick chewing gum is all set to be a reality soon, for a company has completed developing new Clean Gum that can be easily removed from shoes, clothes, pavements and hair.

Revolymer, a spin out company from the University of Bristol, has completed initial street trials on pavements in local high streets as a part of a collaborative agreement with local councils.